Suppr超能文献

西酞普兰(抗抑郁药)通过中脑背内侧下丘脑的 RF 酰胺相关肽在雄性小鼠中引起性功能障碍。

Citalopram (antidepressant) administration causes sexual dysfunction in male mice through RF-amide related peptide in the dorsomedial hypothalamus.

机构信息

Brain Research Institute, School of Medicine and Health Sciences, Monash University, Sunway Campus, Malaysia.

出版信息

Neuropharmacology. 2010 Jul-Aug;59(1-2):77-85. doi: 10.1016/j.neuropharm.2010.03.018. Epub 2010 Apr 8.

Abstract

Citalopram is the most potent selective serotonin reuptake inhibitor (SSRI) which is used as an antidepressant but causes sexual dysfunction. Whether citalopram induced sexual dysfunction is a result of gonadotropin-releasing hormone (GnRH), kisspeptin or RF-amide related peptide (RFRP) alteration is unknown. In this study, we tested mice for sexual behavior after vehicle (0.9% NaCl) and citalopram treatment (5 mg/kg) daily for 1 day (acute) and 21 or 28 days (chronic). Effects of acute and chronic treatments on neuronal numbers and mRNA expression of GnRH, kisspeptin and RFRP were measured. In addition, RFRP fiber projections to preoptic (POA)-GnRH neurons were analyzed using double-label immunohistochemistry. The expression of 14 different serotonin receptor types mRNA was examined in immunostained laser dissected single RFRP neurons in the dorsomedial hypothalamus (DMH), however only 11 receptors types were identified. Acute citalopram treatment did not affect sexual behavior, whereas, the total duration of intromission was reduced with chronic treatment. There was no effect in the expression of kisspeptin (neuronal numbers and mRNA) in the anteroventral periventricular nucleus and the arcuate nucleus and expression of GnRH (neuronal numbers and mRNA) in the POA after citalopram treatment. However, RFRP neuronal numbers in the DMH and fiber projections to the POA were significantly increased after chronic citalopram treatment, which suggests citalopram induced inhibition of sexual behavior involves the modulation of RFRP through serotonin receptors in the DMH.

摘要

西酞普兰是一种最强效的选择性 5-羟色胺再摄取抑制剂(SSRI),被用作抗抑郁药,但会引起性功能障碍。西酞普兰引起的性功能障碍是否是由于促性腺激素释放激素(GnRH)、 kisspeptin 或 RF 酰胺相关肽(RFRP)改变引起的尚不清楚。在这项研究中,我们测试了小鼠在接受载体(0.9%NaCl)和西酞普兰(5mg/kg)治疗 1 天(急性)和 21 或 28 天(慢性)后的性行为。测量了急性和慢性治疗对 GnRH、kisspeptin 和 RFRP 神经元数量和 mRNA 表达的影响。此外,还使用双标记免疫组织化学分析了 RFRP 纤维向视前区(POA)-GnRH 神经元的投射。在免疫染色的激光分离的背内侧下丘脑(DMH)中的单个 RFRP 神经元中,检查了 14 种不同的 5-羟色胺受体类型 mRNA 的表达,但仅鉴定出 11 种受体类型。急性西酞普兰治疗不会影响性行为,而慢性治疗会减少总插入持续时间。在腹侧前脑室下核和弓状核中的 kisspeptin(神经元数量和 mRNA)表达和 POA 中的 GnRH(神经元数量和 mRNA)表达在西酞普兰治疗后没有影响。然而,在慢性西酞普兰治疗后,DMH 中的 RFRP 神经元数量和投射到 POA 的纤维明显增加,这表明西酞普兰诱导的性行为抑制涉及通过 DMH 中的 5-羟色胺受体对 RFRP 的调制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验